Advanced search
Publication Cover
International Journal of General Medicine Volume 16, 2023 - Issue
Submit an article Journal homepage
177
Views
1
CrossRef citations to date
0
Altmetric
Oncology

Prospective Exploratory Study of the Effects of Postoperative Endocrine Medication on the Endometrium in Breast Cancer Patients

Yue He1 Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Maternal and Child Health Care Hospital, Beijing, People’s Republic of ChinaView further author information
,
Yu-He Li1 Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Maternal and Child Health Care Hospital, Beijing, People’s Republic of ChinaView further author information
,
Yu-Ning Geng1 Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Maternal and Child Health Care Hospital, Beijing, People’s Republic of ChinaView further author information
,
Aihui Liu2 Department of Breast, Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Maternal and Child Health Care Hospital, Beijing, People’s Republic of ChinaView further author information
,
Feng-Yun Gao3 Department of Ultrasonography, Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Maternal and Child Health Care Hospital, Beijing, People’s Republic of ChinaView further author information
,
Chen Ji1 Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Maternal and Child Health Care Hospital, Beijing, People’s Republic of ChinaView further author information
,
Yang Liu1 Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Maternal and Child Health Care Hospital, Beijing, People’s Republic of ChinaView further author information
,
Ming Wang1 Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Maternal and Child Health Care Hospital, Beijing, People’s Republic of ChinaView further author information
,
Xing-Ming Li4 School of Public Health Management, Capital Medical University, Beijing, People’s Republic of ChinaView further author information
,
Yan Wang1 Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Maternal and Child Health Care Hospital, Beijing, People’s Republic of ChinaView further author information
&
Yu-Mei Wu1 Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Maternal and Child Health Care Hospital, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 3677-3687 | Received 20 Apr 2023, Accepted 08 Aug 2023, Published online: 22 Aug 2023

References

  • Potkul RK, Unger JM, Livingston RB, et al. Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer. NPJ Breast Cancer. 2016;2:16024. doi:10.1038/npjbcancer.2016.24
  • Li YH, He Y, Yang SL, et al. Progress on relationship between endocrine therapy and endometrial disease in postoperative breast cancer patients and its monitoring. Chin J Pract Gynecol Obstet. 2019;35(8):900–904.
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492
  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132. doi:10.3322/caac.21338
  • Gradishar WJ, Moran MS, Abraham J, et al. NCCN guidelines insights: breast cancer, version 4.2021. JNCCN. 2021;19(5):484–493. doi:10.6004/jnccn.2021.0023
  • Günaldi M, Erkisi M. Evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment. Pharmacol. 2014;94(3–4):183–189. doi:10.1159/000363304
  • Takahashi M, Shimomoto T, Miyajima K, et al. Promotion, but not progression, effects of tamoxifen on uterine carcinogenesis in mic initiated with Nethyl-N’-nitro -N-nitrosoguanidine. Carcinogenesis. 2002;23(9):1549–1555. doi:10.1093/carcin/23.9.1549
  • van de Velde CJ, Verma S, van Nes JG, et al. Switching from tamoxifen to aromatse inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer. Cancer Treat Rev. 2010;36(1):54–62. doi:10.1016/j.ctrv.2009.10.003
  • Uziely B, Lewin A, Brufman A, et al. The effect of tamoxifen on the endometrium[J]. Breast Cancer Res Treat. 1993;26:101–105. doi:10.1007/BF00682705
  • Cardosi RJ, Fiorica JV. Surveillance of the endometrium in Tamoxifen treated women. Curr Opin Obstet Gynecol. 2000;12(1):27–3l. doi:10.1097/00001703-200002000-00005
  • Swerdlow AJ, Jones ME. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J Natl Cancer Inst. 2005;97(5):375–384. doi:10.1093/jnci/dji057
  • Yuan F, Wang FL, Ma DL, et al. Clinical and pathologic analysis of endometrial lesion in postoperative breast cancer patients taking Tamoxifen. Cancer Res Prevent Treat. 2012;39(8):970–972.
  • Lee S, Kim YH, Kim SC, et al. The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer. Obstet Gynecol Sci. 2018;61(5):615–620. doi:10.5468/ogs.2018.61.5.615
  • Le Donne M, Lentini M, De Meo L, et al. Uterine pathologies in patients undergoing tamoxifen therapy for breast cancer: ultrasonographic, hysteroscopic and histological findings. Eur J Gynaecol Oncol. 2005;26:623–626.
  • Wang YL, Chen LZ, Li QG. Clinical and pathologic analysis of endometrial lesion in breast cancer patients taking tamoxifen. Chin J N Clin Med. 2014;7(8):719–721.
  • Wang JL. Scientific evaluation of methods for endometrial cancer screening. Chin J Pract Gynecol Obstet. 2016;32(5):402–405.
  • Guo X, Guan MM, Liu CH, et al. Application of hysteroscopy in the diagnosis and treatment of endometrial cancer. Chin J Pract Gynecol Obstet. 2017;33(1):13–15.
  • Gao WL, Zhang LP, Feng LM. Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen. Chinese Med J. 2011;124(15):2335–2339.
  • Burkart C, Wight E, Pók J, et al. Ultrasound endometrium follow-up during tamoxifen treatment: really not reliable or useful after all? Ultraschall Der Medizin. 2001;22(3):136–142. doi:10.1055/s-2001-15243
  • Dalbert D, Mm R, Figueredo A, et al. Tamoxifen and endometrial disease in patients with breast cancer. Med. 2013;73(2):97–103.
  • Markovitch O, Tepper R, Aviram R, et al. The value of sono⁃hysterography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients. Gynecol Oncol. 2004;94(3):754–759. doi:10.1016/j.ygyno.2004.06.033

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.